Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Point-of-Care Diagnostics, Global Health & Biosensors 2020
Conferences  \  Point-of-Care Diagnostics, Global Health & Biosensors 2020  \  Agenda  \  Richard Chasen Spero
RegisterLogin

Richard Chasen Spero's Biography


Richard Chasen Spero, CEO, Redbud Labs

Richard Spero is co-founder and CEO of Redbud Labs, where he leads both commercial activities and the company’s systems engineering team. He is a co-inventor of Redbud Posts, a MEMS chip covered with biomimetic cilia. Redbud Posts enable novel methods for fluid processing at the microscale, including pumping, mixing, cell sorting, and analyte isolation. This technology is used by point-of-care diagnostic device developers to improve assay speed, reliability, and performance. Prior to founding Redbud Labs, Dr. Spero earned his PhD in Physics at the University of North Carolina at Chapel Hill, where he studied blood clot rheology and developed novel systems for magnetic manipulation and time-dependent high content screening.

Richard Chasen Spero Image

Point-of-Care Molecular Testing and Microfluidic Nucleic Acid Extraction

Tuesday, 29 September 2020 at 13:30

Add to Calendar ▼2020-09-29 13:30:002020-09-29 14:30:00Europe/LondonPoint-of-Care Molecular Testing and Microfluidic Nucleic Acid ExtractionPoint-of-Care Diagnostics, Global Health and Biosensors 2020 in Virtual ConferenceVirtual ConferenceSELECTBIOenquiries@selectbiosciences.com

Point-of-care molecular tests have a reputation for inferior sensitivity when compared to their laboratory competition. Sample preparation is the single biggest barrier to high-sensitivity molecular testing at point-of-care. In the laboratory, column- and magnetic bead-based workflows are the gold standard. Microfluidic systems, by contrast, have no widely adopted standard for nucleic acid extraction, despite decades of research. We present our work to port the gold-standard nucleic acid extraction workflow using magnetic beads onto microfluidic cartridges.

Add to Calendar ▼2020-09-28 00:00:002020-09-30 00:00:00Europe/LondonPoint-of-Care Diagnostics, Global Health and Biosensors 2020Point-of-Care Diagnostics, Global Health and Biosensors 2020 in Virtual ConferenceVirtual ConferenceSELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors
Related Conferences
Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024
Location: New Orleans
Date: 26/09/2024 - 27/09/2024


Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing
Location: Ann Arbor, Michigan
Date: 06/05/2024 - 07/05/2024


Lab-on-a-Chip and Microfluidics Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024